Related Experiment Videos

The prevalence of hyperlipoproteinaemia in vascular disease

Insights

Hyperlipoproteinaemia (HLP), a condition of high blood lipids, is common in Scotland. Type IV HLP is more prevalent in males, while survivors of heart attacks show high rates of HLP, particularly type II and IV.

Area of Science:

  • Cardiovascular Epidemiology
  • Metabolic Disorders
  • Public Health

Background:

  • Hyperlipoproteinaemia (HLP) is a significant risk factor for cardiovascular diseases.
  • Prevalence studies are crucial for understanding population health and disease burden.

Purpose of the Study:

  • To determine the prevalence of hyperlipoproteinaemia in the West of Scotland working population.
  • To investigate the distribution of different HLP types across various demographic groups and disease states.

Main Methods:

  • Cross-sectional survey of apparently healthy working individuals.
  • Analysis of HLP prevalence in subgroups: general population, myocardial infarction survivors, peripheral vascular disease patients, and cerebrovascular disease patients.

Main Results:

  • High prevalence of HLP observed in the West of Scotland working population.
  • Type IV HLP was more common in males (12%) than females (3.3%), influenced by obesity.
  • HLP was frequent in myocardial infarction survivors (61%), with types II (39%) and IV (22%) predominating.
  • Peripheral vascular disease patients had 38% HLP, with higher rates in females (47%) than males (32%), mainly due to type IIa.
  • HLP did not show a significant association with cerebrovascular disease.

Conclusions:

  • HLP is a prevalent condition in the studied population, varying by sex and disease context.
  • Specific HLP types are associated with different cardiovascular conditions, suggesting distinct pathophysiological roles.
  • Further research into targeted HLP management strategies for different patient groups is warranted.

Related Concept Videos